Company: NDRA
Filing Date: 2025-07-16
Form Type: S-1/A
Source: 0001654954-25-008117
Chunk: 48

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-16
Form: S-1/A
Chunk 48
---
       |

The Underwriting Agreement provides that the obligations of the Underwriter to purchase the shares included in this offering are subject to approval of legal matters by counsel and to other conditions. The Underwriting Agreement provides that the Underwriter will purchase all of the securities if any of them are purchased.

Securities sold by the Underwriter to the public will initially be offered at the public offering prices set forth on the cover of this prospectus. In addition, the Underwriter may offer some of the securities to other securities dealers at such price less a concession of $ per share. After the initial offering of the securities, the public offering price or any other term of the offering may be changed by the Underwriter.

Underwriting discounts and commissions

We are offering shares of our common stock and Pre-Funded Warrants pursuant to this prospectus. The following table shows the effective public offering price, underwriting discounts and commissions, and proceeds before expenses to us.

|                                                                                 |     | Effective Price Per Share |     | Effective Price Per Pre-Funded Warrant |     | Total Without Option |     | Total With Option |
|:--------------------------------------------------------------------------------|:----|:--------------------------|:----|:---------------------------------------|:----|:---------------------|:----|:------------------|
| Public offering price                                                           |     | $                         |     | $                                      |     | $                    |     | $                 |
| Underwriting discounts and commissions payable by us, before expenses, to us(1) |     | $                         |     | $                                      |     | $                    |     | $                 |
| Proceeds, before expenses, to us                                                |     | $                         |     | $                                      |     | $                    |     | $                 |

(1) The underwriting discount is 7.0% of the gross proceeds received from the sale of securities to all purchasers in the offering.

Underwriter Warrants

We have also agreed to sell for a nominal price to the Underwriter or its designees at the closing of this offering, warrants to purchase a number of shares of common stock equal to 4.0% of the aggregate number of shares of common stock and Pre-Funded Warrants sold in this offering, at an exercise price equal to 150% of the public offering price for the shares of common stock issued in this offering. The Underwriter Warrants will be exercisable upon issuance, in whole or in part, and will expire three years from the commencement of sales in this offering. The Underwriter Warrants and the